SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Licht, R
Right arrow Articles by Berden, J H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Licht, R
Right arrow Articles by Berden, J H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

No constitutive defect in phagocytosis of apoptotic cells by resident peritoneal macrophages from pre-morbid lupus mice

R Licht

C WM Jacobs

W JM Tax

Division of Nephrology, University Medical Centre Nijmegen, Nijmegen, The Netherlands

J HM Berden

Division of Nephrology (545), University Medical Centre Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands; J.Berden{at}nefro.azn.nl

Antibodies against nucleosomes are a hallmark of systemic lupus erythematosus (SLE). Nucleosomes are uniquely formed during apoptosis, through cleavage of chromatin by nucleases. Increased exposure of nucleosomes to the immune system could play a role in the induction of the autoimmune repertoire in SLE. To determine whether there exists a constitutive defect in the clearance of apoptotic cells, resident peritoneal macrophages from pre-morbid SLE-prone MRL and New Zealand (NZ) mice were analysed for their efficacy to phagocytose apoptotic cells in vitro. Although differences in phagocytic efficacy of up to 50% between different strains of mice were found, these were not related to SLE development. To evaluate whether macrophages from SLE-prone mice are more susceptible to phagocytic ‘exhaustion’, resident peritoneal macrophages were challenged by 20 h of additional culture in the presence of apoptotic cells. In both lupus and control strains this led to an increased capacity to phagocytose fresh apoptotic cells (increase between 15 and 92%). As a control, macrophages from all strains were also exposed to 20 h of additional culture without apoptotic cells. Under this condition resident peritoneal macrophages from all SLE-prone strains, and of the SLE-parental strain NZB, displayed a significant decrease in their efficacy to phagocytose apoptotic cells (decrease between 16 and 55%). Together, these findings do not support the hypothesis that a constitutive defect in the clearance of apoptotic cells, as evaluated by testing resident peritoneal macrophages, plays an important role in the induction of SLE.

Key Words: phagocytosis • apoptosis • mouse • lupus erythematosus

Lupus, Vol. 10, No. 2, 102-107 (2001)
DOI: 10.1191/096120301672276558


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
A. F. M. Maree, M. Komba, D. T. Finegood, and L. Edelstein-Keshet
A quantitative comparison of rates of phagocytosis and digestion of apoptotic cells by macrophages from normal (BALB/c) and diabetes-prone (NOD) mice
J Appl Physiol, January 1, 2008; 104(1): 157 - 169.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc AHome page
A. F.M Maree, R. Kublik, D. T Finegood, and L. Edelstein-Keshet
Modelling the onset of Type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease?
Phil Trans R Soc A, May 15, 2006; 364(1842): 1267 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Bijl, E Reefman, G Horst, P C Limburg, and C G M Kallenberg
Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement
Ann Rheum Dis, January 1, 2006; 65(1): 57 - 63.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. W. C. Dieker, J. van der Vlag, and J. H. M. Berden
Deranged removal of apoptotic cells: its role in the genesis of lupus
Nephrol. Dial. Transplant., February 1, 2004; 19(2): 282 - 285.
[Full Text] [PDF]


Home page
J. Immunol.Home page
P. K. Potter, J. Cortes-Hernandez, P. Quartier, M. Botto, and M. J. Walport
Lupus-Prone Mice Have an Abnormal Response to Thioglycolate and an Impaired Clearance of Apoptotic Cells
J. Immunol., March 15, 2003; 170(6): 3223 - 3232.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
J W. Dieker, J van der Vlag, and J H. Berden
Triggers for anti-chromatin autoantibody production in SLE
Lupus, December 1, 2002; 11(12): 856 - 864.
[Abstract] [PDF]


Home page
DiabetesHome page
B. A. O'Brien, Y. Huang, X. Geng, J. P. Dutz, and D. T. Finegood
Phagocytosis of Apoptotic Cells by Macrophages From NOD Mice Is Reduced
Diabetes, August 1, 2002; 51(8): 2481 - 2488.
[Abstract] [Full Text] [PDF]



Advertisement